- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 275/04 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 275/04
Total number of patents in this class: 171
10-year publication summary
9
|
8
|
8
|
11
|
8
|
13
|
7
|
3
|
8
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Amgen Inc. | 4074 |
8 |
Titan Chemicals Limited | 8 |
5 |
BASF SE | 20933 |
4 |
Emory University | 1626 |
4 |
Sumitomo Seika Chemicals Co., Ltd. | 1039 |
4 |
Yale University | 2378 |
4 |
Abbott Laboratories | 2399 |
3 |
Allergan, Inc. | 2349 |
3 |
FUJIFILM Corporation | 29367 |
3 |
CHDI Foundation, Inc. | 108 |
3 |
J-pharma Co., Ltd. | 26 |
3 |
Nippon Chemiphar Co., Ltd. | 229 |
3 |
Thor GmbH | 65 |
3 |
Troy Corporation | 47 |
3 |
Dethree Res. Lab. Inc. | 3 |
3 |
Zhejiang Jingxin Pharmaceutical Co., Ltd. | 21 |
3 |
The Regents of the University of California | 19918 |
2 |
Bayer Cropscience AG | 2035 |
2 |
Rohm and Haas Company | 2906 |
2 |
The Trustees of Columbia University in the City of New York | 3568 |
2 |
Other owners | 104 |